Global brokerage firm Jefferies has upgraded Zydus Lifesciences to a ‘Buy’ rating, citing the strength of the company’s US pipeline as a major growth driver. Jefferies raised its target price to Rs 1,450 from Rs 1,210, indicating a 30% upside from the previous closing price of Rs 1,113.80.
Tech view: Nifty’s positive sentiment on verge of negation, crucial support at 23,500. How to trade on Monday
Nifty closed below key support at 23,500, signaling further downside risk. Analysts highlight bearish momentum, with potential declines toward 23,260 or lower. Immediate resistance lies